Document Detail

Complementary medicine for prostate cancer: effects of soy and fat consumption.
MedLine Citation:
PMID:  16985997     Owner:  NLM     Status:  In-Data-Review    
Complementary medicine has become an increasing area of interest for patients and researchers around the world. The utilization of some of these therapies by many individuals makes it imperative to understand if they have a role in cancer or other disease treatment. Soy products have generated a large interest because a variety of laboratory and epidemiologic research suggests these items may play a role in the prevention of prostate cancer. Clinical trials are addressing this issue and whether or not these products could also improve prognosis of prostate cancer. Additionally, other soy-based capsules (ipriflavone) have received some research, but the largest clinical study to date does not support the use of these supplements to reduce hot flashes and/or osteoporosis risk. Dietary fat reduction to prevent prostate cancer is supported by numerous case-control studies over the past 25 years. However, recent prospective studies suggest that fat reduction may not play a strong role in prevention of prostate carcinoma. Soy products and fat reduction may have a symbiotic relationship. Any healthy lifestyle or dietary change should be encouraged, because it may reduce the risk of cardiovascular disease, which is still the number one cause of mortality.
M A Moyad; W A Sakr; D Hirano; G J Miller
Related Documents :
25023197 - Combined genetic and nutritional risk models of triple negative breast cancer.
25107527 - The dynamic range of circulating tumor dna in metastatic breast cancer.
1995917 - A cohort study of fat intake and risk of breast cancer.
24460267 - Common variants in the palb2 gene confer susceptibility to breast cancer: a meta-analysis.
25124587 - Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
15074307 - Aberrant methylation of socs-1 was observed in younger colorectal cancer patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reviews in urology     Volume:  3 Suppl 2     ISSN:  1523-6161     ISO Abbreviation:  Rev Urol     Publication Date:  2001  
Date Detail:
Created Date:  2006-09-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889067     Medline TA:  Rev Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S20-30     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prostate cancer pathology, screening, and epidemiology.
Next Document:  Prostate cancer: risk assessment and diagnostic approaches.